IMS vs. Vermont: Free Speech but only in the Interest of the Government
Free Speech but only in the interest of the Goverment.
This is exactly what the NLARX has stated in their press release about the…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2008
Massachusetts S2660 – The Sun is Shining in San Diego
Recently, we reported that it would be cloudy for the Massachusetts delegation at BIO 2008. Massachusetts S2660 – San Diego…
Macy Conference – Missed Opportunity
We see the Conference as a missed opportunity. This is how the chief executive officers of the major CE accrediting bodies…
AMA CEJA – Back to the Drawing
Today the AMA House of Delegates soundly rejected the CEJA recommendations Report 1 of The Council on Ethical and Judicial…
AMA CEJA – Former JAMA editor suggest withdrawal
George Lundberg, MD Editor of Medscape Journal of Medicine and former Editor and Chief of the Journal of the American Medical…
ACCME Supported Study Shows No Evidence to End Commercial Support
Where is the Beef?
This is the question that was answered by a study commissioned by the Accreditation Council for…
AMA CEJA — A Chorus of Voices Say (Vote NO)
A group of key influential leaders in CME along with others are standing up to ask the AMA House of Delegates to reconsider…
AMA CEJA – How Did We Get Here
Thomas Stossel, MD, Chairman of the Division of Translational Medicine at Harvard has written a very insightful editorial…
AMA CEJA — Doctors Say Vote NO
For the last Sevin days, Medscape has asked physician’s their thoughts on AMA CEJA recommendations to ban commercial support of…
AMA CEJA — More Groups Line Up Against
In the last few days, two organizations: the AAMSE and ACME, released their positions on CEJA: Report 1 of The Council on…